The role of reverse genetics in the development of vaccines against respiratory viruses.

Authors:
Marsh GA; Tannock GA.

Journal:
Expert Opin Biol Ther

Publication Year: 2005

DOI:
10.1517/14712598.5.3.369

PMCID:
PMC7105756

PMID:
15833074

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Expert Opin Biol Ther

Abbreviation: Expert Opin Biol Ther

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Therapeutics

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Immune checkpoint inhibition in COVID-19: risks and benefits.
Pezeshki PS; Rezaei N. (2021) - Transparency Score: 1/6
Tafasitamab for the treatment of relapsed or refractory diffuse large B-cell lymphoma.
Salles G; Długosz-Danecka M; Ghesquières H and 1 more (2021) - Transparency Score: 2/6
Diabetic retinopathy: a complex pathophysiology requiring novel therapeutic strategies.
Whitehead M; Wickremasinghe S; Osborne A and 2 more (2018) - Transparency Score: 2/6
Golimumab for the treatment of ulcerative colitis.
Flamant M; Paul S; Roblin X. (2017) - Transparency Score: 2/6
The use of the NIS reporter gene for optimizing oncolytic virotherapy.
Miller A; Russell SJ. (2015) - Transparency Score: 2/6
View All Papers from This Journal
Transparency Score
0/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
COI Disclosure
Funding Disclosure
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025